Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.

about

Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation Protein quantitative trait locus study in obesity during weight-loss identifies a leptin regulator.Serpin functions in host-pathogen interactions.

P2860

Q33820434-5114B671-1771-46E8-9052-B58BA6857456 Q47114695-47ED3ED6-9679-4900-9BDD-10C69BD06A2D Q52597535-7D384EA1-0BCF-4CE6-A02C-460145B2775D

P2860

Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.

Item

http://www.wikidata.org/entity/Q38838756

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Increased kallistatin levels i ...... d to normal glucose tolerance.

@en

type

Item

label

Increased kallistatin levels i ...... d to normal glucose tolerance.

@en

prefLabel

Increased kallistatin levels i ...... d to normal glucose tolerance.

@en

P1476

Increased kallistatin levels i ...... ed to normal glucose tolerance

@en

P2093

Antoaneta Gateva

http://www.w3.org/2001/XMLSchema#string

Zdravko Kamenov

http://www.w3.org/2001/XMLSchema#string

P2860

Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.

Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling

Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation

Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range.

Kallistatin is a new inhibitor of angiogenesis and tumor growth.

Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.

Localization and expression of tissue kallikrein and kallistatin in human blood vessels.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.

Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.

P304

163-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07435800.2017.1286671

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsvetelina Velikova

Yavor Assyov

P577

2017-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28406338

http://www.w3.org/2001/XMLSchema#string

Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.

about

P2860

P2860

Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698